Cargando…
Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475457/ https://www.ncbi.nlm.nih.gov/pubmed/37661200 http://dx.doi.org/10.1038/s41392-023-01523-3 |
| _version_ | 1785100722780504064 |
|---|---|
| author | Yang, Xiao-mei Lin, Xuan-dong Shi, Wei Xie, Shen-xia Huang, Xia-ning Yin, Shi-hua Jiang, Xiao-bing Hammock, Bruce D. Xu, Zhi Ping Lu, Xiao-ling |
| author_facet | Yang, Xiao-mei Lin, Xuan-dong Shi, Wei Xie, Shen-xia Huang, Xia-ning Yin, Shi-hua Jiang, Xiao-bing Hammock, Bruce D. Xu, Zhi Ping Lu, Xiao-ling |
| author_sort | Yang, Xiao-mei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10475457 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104754572023-09-05 Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy Yang, Xiao-mei Lin, Xuan-dong Shi, Wei Xie, Shen-xia Huang, Xia-ning Yin, Shi-hua Jiang, Xiao-bing Hammock, Bruce D. Xu, Zhi Ping Lu, Xiao-ling Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-09-04 /pmc/articles/PMC10475457/ /pubmed/37661200 http://dx.doi.org/10.1038/s41392-023-01523-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Yang, Xiao-mei Lin, Xuan-dong Shi, Wei Xie, Shen-xia Huang, Xia-ning Yin, Shi-hua Jiang, Xiao-bing Hammock, Bruce D. Xu, Zhi Ping Lu, Xiao-ling Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy |
| title | Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy |
| title_full | Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy |
| title_fullStr | Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy |
| title_full_unstemmed | Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy |
| title_short | Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy |
| title_sort | nanobody-based bispecific t-cell engager (nb-bite): a new platform for enhanced t-cell immunotherapy |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475457/ https://www.ncbi.nlm.nih.gov/pubmed/37661200 http://dx.doi.org/10.1038/s41392-023-01523-3 |
| work_keys_str_mv | AT yangxiaomei nanobodybasedbispecifictcellengagernbbiteanewplatformforenhancedtcellimmunotherapy AT linxuandong nanobodybasedbispecifictcellengagernbbiteanewplatformforenhancedtcellimmunotherapy AT shiwei nanobodybasedbispecifictcellengagernbbiteanewplatformforenhancedtcellimmunotherapy AT xieshenxia nanobodybasedbispecifictcellengagernbbiteanewplatformforenhancedtcellimmunotherapy AT huangxianing nanobodybasedbispecifictcellengagernbbiteanewplatformforenhancedtcellimmunotherapy AT yinshihua nanobodybasedbispecifictcellengagernbbiteanewplatformforenhancedtcellimmunotherapy AT jiangxiaobing nanobodybasedbispecifictcellengagernbbiteanewplatformforenhancedtcellimmunotherapy AT hammockbruced nanobodybasedbispecifictcellengagernbbiteanewplatformforenhancedtcellimmunotherapy AT xuzhiping nanobodybasedbispecifictcellengagernbbiteanewplatformforenhancedtcellimmunotherapy AT luxiaoling nanobodybasedbispecifictcellengagernbbiteanewplatformforenhancedtcellimmunotherapy |